Premium
O2‐15‐01: THE DIFFERENTIAL INFLUENCE OF IMMUNE, ENDOCYTOTIC AND LIPID METABOLISM GENES ON AMYLOID DEPOSITION AND NEURODEGENERATION IN ALZHEIMER'S DISEASE
Author(s) -
Femminella Grazia Daniela,
Talib Sophie,
Harold Denise,
Williams Julie,
Edison Paul
Publication year - 2018
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2018.06.2724
Subject(s) - dementia , apolipoprotein e , medicine , neurodegeneration , neurocognitive , framingham risk score , oncology , disease , alzheimer's disease , cognitive decline , amyloid beta , population , endocrinology , psychology , cognition , psychiatry , environmental health
USA; University of North Carolina, Chapel Hill, NC, USA; Memory and Aging Center, UCSF Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA; Texas Health Presbyterian Hospital Dallas, Dallas, TX, USA; National Alzheimer’s Coordinating Center, University of Washington, Seattle, WA, USA; University of California San Diego, San Diego, CA, USA; National Institutes of Health, Washington, DC, USA; University of British Columbia, Vancouver, BC, Canada; Greater Los Angeles VA Healthcare System, Los Angeles, CA, USA; University of California, San Francisco, San Francisco, CA, USA; Johns Hopkins University, Baltimore, MD, USA; Johns Hopkins University School of Medicine, Baltimore, MD, USA; University of Alabama at Birmingham, Birmingham, AL, USA; NIH, Bethesda, MD, USA; Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada; Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA; Northwestern University, Chicago, IL, USA. Contact e-mail: adam.boxer@ucsf.edu